Commenting on the results, Vas Narasimhan, CEO of Novartis, said: “We progressed our breakthrough medicines pipeline including our leading advanced therapy platforms in cell and gene and continued our strong operational performance.”
Today, Novartis CEO Vas Narasimhan announced the company’s financial results for the third quarter of 2018.
Oct 18, 2018